PowerFeed® A Chemically Defined and Protein-free Powder, 10L
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 10 L powder kit (NAO)
ProCHO® 5 Protein-free CHO Medium Powder kit with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 500 L (NAO)
PowerCHO® 2 Powder kit 100 L, with HEPES, Pluronic® F-68, without L-Glutamine, Phenol red, hypoxanthine or thymidine
PowerCHO® 2 Powder Kit 10L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 50L powder kit (NAO)
PowerCHO® 2 Powder Kit 50 L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
PowerCHO® 2 Powder Kit 500 L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
RPMI 1640 Powder without phenol red, NaHCO3 and L-glutamine, 1000L
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Large-scale editing of human T cells -
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell ExpansionThis poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.